Zonisamide: A review of the clinical and experimental evidence for its use in Parkinson′s disease

唑尼沙胺 医学 临床试验 左旋多巴 帕金森病 疾病 不利影响 随机对照试验 纳入和排除标准 癫痫 重症监护医学 内科学 托吡酯 精神科 替代医学 病理
作者
NeetaD Grover,Ramchandra Prabhakar Limaye,DilipV Gokhale,TatyasahebR Patil
出处
期刊:Indian Journal of Pharmacology [Medknow]
卷期号:45 (6): 547-547 被引量:22
标识
DOI:10.4103/0253-7613.121266
摘要

The limitations of currently available therapies in addressing the non motor symptoms of Parkinson's disease (PD) have egged on the search for newer options. Zonisamide has been in use for epilepsy and it was serendipitously found to improve the symptoms of PD in a patient who had both epilepsy and PD. Thereafter, various trials were designed to assess the use of zonisamide in PD. The present article investigates the evidence for use of zonisamide in PD from the various clinical trials that were designed to address this issue. Furthermore, the article also summarizes the various mechanisms of its use in PD as described in various animal experiments. A search protocol was designed with predefined inclusion and exclusion criteria. The databases searched were Pubmed, Ovid medline, Cochrane and clinicaltrials.gov. The data thus generated, was fed into a predesigned format. Most of the clinical trials on zonisamide in PD have come from Japan. Most of these trials used the changes in the Unified Parkinson's Disease Rating Scale (UPDRS) score as the endpoints and the most conclusive evidence is for a dose of 25-50 mg, which caused a change in UPDRS part III (motor symptoms). These patients were on levodopa and other drugs used for PD during the trials. One of the clinical trials conducted in Spain investigates the use of zonisamide in impulse control disorders among 15 patients of PD. Among the many mechanisms postulated, a reduction in levodopa induced quinone formation, protection against mitochondrial impairment and an increase in astroglial cysteine transport, an inhibition of microglial activation, monoamine oxidase-B (MAO-B) inhibition, an increased dopamine release and blockade of calcium channels are the most cited. There is evidence for use of zonisamide in PD in addition to levodopa and other therapies for control of motor symptoms. For now, the evidence for its use in control of non motor symptoms in PD is not enough and needs to be investigated further.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
FFF团团长发布了新的文献求助10
刚刚
Hhong完成签到,获得积分10
1秒前
娜娜完成签到,获得积分0
1秒前
蓝梦之旅完成签到,获得积分10
1秒前
2秒前
yangching完成签到,获得积分10
2秒前
儒雅的石头完成签到,获得积分10
2秒前
顾矜的应助被369ninja采纳,获得10
2秒前
liangzai完成签到,获得积分10
2秒前
3秒前
阳明爸爸完成签到,获得积分10
3秒前
wwwteng呀发布了新的文献求助10
3秒前
xxx完成签到,获得积分10
3秒前
Nicholas完成签到,获得积分10
4秒前
大猫完成签到,获得积分10
4秒前
kooolooo完成签到 ,获得积分10
4秒前
4秒前
彳亍而上学完成签到,获得积分10
5秒前
熊大完成签到,获得积分10
5秒前
含着朵白云完成签到 ,获得积分10
6秒前
我真的晕完成签到,获得积分10
6秒前
慈祥的爆米花完成签到,获得积分10
6秒前
LG完成签到 ,获得积分10
6秒前
FashionBoy的应助被科研通管家采纳,获得10
7秒前
elang发布了新的文献求助10
7秒前
syvshc的应助被科研通管家采纳,获得10
7秒前
斯文败类的应助被科研通管家采纳,获得10
7秒前
SciGPT的应助被科研通管家采纳,获得10
7秒前
Daniel完成签到,获得积分10
7秒前
思源的应助被科研通管家采纳,获得10
7秒前
suzhenyue的应助被科研通管家采纳,获得10
7秒前
单薄涵梅完成签到,获得积分10
7秒前
小二_来篇一作完成签到,获得积分10
7秒前
7秒前
Jin完成签到,获得积分10
8秒前
Akim的应助被科研通管家采纳,获得10
8秒前
Firsterchao的应助被科研通管家采纳,获得10
8秒前
Lin完成签到,获得积分10
8秒前
听风无涯完成签到,获得积分10
8秒前
思源的应助被科研通管家采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180146
求助须知:如何正确求助?哪些是违规求助? 9570319
关于积分的说明 21809739
捐赠科研通 7776294
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479039